New research presented at the Prostate Cancer Foundation
of New Zealand’s (PCFNZ) annual conference held at the end
of August showed a late diagnosis of prostate cancer not
only contributes to negative health outcomes for New Zealand
men, adversely affects their employment earnings by an
average of $12,000 over four years, compared to no loss of
earnings with an early diagnosis.
The research was
presented by Sarah Hogan, New Zealand Institute of Economic
Research (NZIER), Principal Economist at the conference,
which this year focused on early detection and
survivorship.
NZIER matched 969 prostate cancer
participants to a non-cancer control group in terms of
similar demographics, health status, health service
utilisation, employment, earnings, and income support
status. By using exact case and propensity score matching,
with minimal sample loss occurring, higher quality data was
captured with a lower proportion of bias.
“While
$12,000 in lost earnings over four years, was the average
for the research group, the older men were at diagnosis
seems to significantly impact lost earnings. We saw an
average earning loss of $17,606 for men aged 60-64 at
diagnosis versus $9,278 for younger men under 60,” says
Hogan.
“This raises questions as to whether the
health system, in relation to the diagnosis of prostate
cancer, is disproportionately disadvantaging older men, who
still have considerable earning potential for years to
come.
“Or is the greater loss of income down to
older men feeling forced into reducing their working hours
or changing their type of employment following their
diagnosis, while their younger counterparts feel more
confident to continue to earn? With an average life
expectancy for New Zealand men of 80 years the potential
impact of forced early retirement and $17,606 in lost
earnings over four years is substantial.”
According
to Prostate Cancer Foundation New Zealand (PCFNZ) 42,000 men
are currently living in New Zealand with prostate
cancer.
“Using the NZ Cancer Registry codes for
diagnosis, nearly 60% of all prostate cancer patients
experience a late diagnosis. That means 24,780 of these men
will experience an average loss of earnings of $12,000 –
earlier diagnosis could potentially have avoided a total
loss of over $300 million in reduced earnings,” says
Hogan.
The research also shows younger men (under 60)
who receive a late prostate cancer diagnosis have a
statistically significant probability of increased social
welfare dependency six months post-diagnosis. So, not only
are men experiencing loss of earnings through late
diagnosis, their risk of unemployment and reliance on social
welfare support increased.
For Māori men a late
diagnosis also translates to significant lost earnings.
Hogan found that the late diagnosis group amongst Māori
mean saw an earnings loss of approximately 9% suggesting
these individuals were significantly financially impacted by
their late cancer diagnosis.
This is supported by
further investigation into welfare dependency and employment
for Māori men, which showed an increased reliance on social
welfare 48 months after diagnosis compared with matched
controls. Māori men also experienced a statistically
significant impact on reduction in employment status. These
findings are important equity considerations as Māori men
are more likely to be diagnosed late and more likely to earn
lower incomes to begin with.
Peter Dickens, the
Prostate Cancer Foundation’s CEO says, “If we could
ensure every man with prostate cancer was diagnosed early
via a simple PSA blood test, we could reduce the number of
deaths by 40% and save 280 dads, partners, colleagues,
brothers, friends, and sons every year.
“Early
diagnosis delivers better health outcomes, prevents New
Zealand men from dying needlessly and avoids the loss of
millions of dollars of earnings. The research from NZIER
clearly shows that early diagnosis significantly reduces the
financial burden on men and their whānau – $300 million
is a staggering number of potentially avoidable lost
earnings. Added to this the increased probability of welfare
dependency and the outlook of a late prostate cancer
diagnosis makes for pretty bleak realities for Kiwi
men.”
PCFNZ is committed to advocating for New
Zealand men living with prostate cancer, to ensure they get
better health outcomes. By supporting Blue September,
PCFNZ’s primary fundraising event, you will be supporting
the 1 in 8 Kiwi men affected by prostate cancer. ‘Do
Something Blue’ to help a mate through during the month of
September and help give a voice to New Zealand men living
with prostate cancer – www.blueseptember.org.nz.
© Scoop Media



















Discussion about this post